Clonazepam Tapering Protocol Guidelines
Introduction to Tapering
- The American College of Physicians and other medical societies recommend against abrupt discontinuation of benzodiazepines like clonazepam, as it can cause life-threatening withdrawal reactions, including seizures, delirium, and death, with risks comparable to suddenly stopping antihypertensives or antihyperglycemics 1
Evidence-Based Tapering Schedule
- The Mayo Clinic recommends reducing clonazepam by 0.5 mg every 2 weeks for patients on >1 mg/day, and by 0.25 mg per week for patients on ≤1 mg/day, with a total duration of 4-7 months 1
- The Centers for Disease Control and Prevention (CDC) suggests that long-term users (≥1 year) require slower tapers over several months to years, with 10% per month reductions or slower 3
Patient Preparation and Monitoring
- The Mayo Clinic Proceedings suggest establishing a collaborative agreement on tapering goals and timeline, explaining expected withdrawal symptoms and management strategies, and setting realistic expectations, with frequent follow-up appointments every 2-4 weeks 1
- The Mayo Clinic recommends assessing withdrawal symptoms using standardized scales, monitoring for return of original anxiety/panic symptoms, screening for depression, suicidal ideation, and substance use, and documenting response to adjust taper speed accordingly 1
Managing Withdrawal Symptoms
- The Mayo Clinic Proceedings recommend temporarily returning to the previous dose until symptoms stabilize, attempting a smaller reduction, extending time between reductions to 4-6 weeks, and considering adjunctive medications for specific symptoms, such as trazodone for insomnia 1, 2
Special Considerations
- The CDC recommends considering maintenance at a reduced dose rather than complete discontinuation for patients unable to taper, with the target dose not being zero 1
- The Mayo Clinic Proceedings suggest that some patients may benefit from resumption at lower doses after attempted elimination 1